EU ingredient rules · 1 min read

Methoxy Peg-114/polyepsilon Caprolactone in cosmetics: EU rules

Quick answer: Methoxy Peg-114/polyepsilon Caprolactone is a restricted cosmetic ingredient in the EU: Annex III (entry 186) allows it only within set limits, at up to 0.1% in the ready-to-use product. CosIng lists its functions as buffering, film forming and hair conditioning.

Key facts

Methoxy Peg-114/polyepsilon Caprolactone at a glance
INCI nameMETHOXY PEG-114/POLYEPSILON CAPROLACTONE
EU statusRestricted (Annex III, entry 186)
Functions (CosIng)Buffering, Film forming, Hair conditioning

CosIng description: Methylpoly(oxyethylene)poly(oxy-1-oxohexylene)ol (114 mol EO average)

What it does in a product

  • Buffering: Keeps a product's pH steady.
  • Film forming: Leaves a thin, continuous layer on skin, hair or nails.
  • Hair conditioning: Makes hair easier to comb and leaves it softer or shinier.

Annex III: restricted substances, entry 186

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as 2,2'-oxydiethanol Diethylene glycol (DEG)

Maximum concentration in the ready-to-use product: 0.1%

Product type or body part:

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2013/344.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for METHOXY PEG-114/POLYEPSILON CAPROLACTONE and Annex III/186, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.